LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease

[1]  M. Farrer,et al.  Association of the MAPT locus with Parkinson’s disease , 2010, European journal of neurology.

[2]  M. Farrer,et al.  LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. , 2010, Parkinsonism & related disorders.

[3]  Y. Teo,et al.  LINGO1 VARIANT INCREASES RISK OF FAMILIAL ESSENTIAL TREMOR , 2009, Neurology.

[4]  Sonja W. Scholz,et al.  SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.

[5]  H. Stefánsson,et al.  Variant in the sequence of the LINGO1 gene confers risk of essential tremor , 2009, Nature Genetics.

[6]  Haydar Sur,et al.  Prevalence of essential tremor: a door-to-door survey in Sile, Istanbul, Turkey. , 2009, Parkinsonism & related disorders.

[7]  H. Andrews,et al.  Prevalence of Essential Tremor in a Multiethnic, Community-Based Study in Northern Manhattan, New York, N.Y. , 2009, Neuroepidemiology.

[8]  J. Benito-León,et al.  Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  H. Yaginuma,et al.  Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. , 2009, Gene expression patterns : GEP.

[10]  D. Hernandez,et al.  Neurofibrillary tau pathology modulated by genetic variation of α‐synuclein , 2008, Annals of neurology.

[11]  A. Antonini,et al.  Striatal dopamine transporter abnormalities in patients with essential tremor , 2008, Nuclear medicine communications.

[12]  A. Sandrock,et al.  LINGO-1 and its role in CNS repair. , 2008, The international journal of biochemistry & cell biology.

[13]  P. Rigby,et al.  Expression of the Lingo/LERN gene family during mouse embryogenesis. , 2008, Gene expression patterns : GEP.

[14]  K. Lyons,et al.  Neuropathological changes in essential tremor: 33 cases compared with 21 controls. , 2007, Brain : a journal of neurology.

[15]  Li Wang,et al.  LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis , 2007, Nature Medicine.

[16]  T. Engber,et al.  Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models , 2007, Proceedings of the National Academy of Sciences.

[17]  M. Ban,et al.  Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease , 2007 .

[18]  Eden R Martin,et al.  No gene is an island: the flip-flop phenomenon. , 2007, American journal of human genetics.

[19]  J. Relton,et al.  LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury , 2006, Molecular and Cellular Neuroscience.

[20]  M. Farrer.  Genetics of Parkinson disease: paradigm shifts and future prospects , 2006, Nature Reviews Genetics.

[21]  M. Farrer,et al.  Lrrk2 pathogenic substitutions in Parkinson's disease , 2005, Neurogenetics.

[22]  B. Trapp,et al.  LINGO-1 negatively regulates myelination by oligodendrocytes , 2005, Nature Neuroscience.

[23]  John M. McCoy,et al.  TAJ/TROY, an Orphan TNF Receptor Family Member, Binds Nogo-66 Receptor 1 and Regulates Axonal Regeneration , 2005, Neuron.

[24]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[25]  S. Strittmatter,et al.  A Neutralizing Anti-Nogo66 Receptor Monoclonal Antibody Reverses Inhibition of Neurite Outgrowth by Central Nervous System Myelin* , 2004, Journal of Biological Chemistry.

[26]  J. Relton,et al.  LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex , 2004, Nature Neuroscience.

[27]  X. Estivill,et al.  LRRN6A/LERN1 (leucine‐rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex , 2003, The European journal of neuroscience.

[28]  D. Dickson,et al.  Alpha-synuclein and the Lewy body disorders. , 2001, Current opinion in neurology.

[29]  A. Hofman,et al.  Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[30]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[31]  H. Andrews,et al.  Diagnostic criteria for essential tremor: a population perspective. , 1998, Archives of neurology.